(R)-(-)-Docosahexaenyl-2'-Hydroxy-1'-Propylamide

(R)-(-)-Docosahexaenyl-2'-Hydroxy-1'-Propylamide
Artikelnummer
CAY9001230-5
Verpackungseinheit
5 mg
Hersteller
Cayman Chemical

Verfügbarkeit: wird geladen...
Preis wird geladen...
Formulation: A solution in ethanol

Formal Name: N-((R)-2-hydroxypropyl)docosa-4Z,7Z,10Z,13Z,16Z,19Z-hexaenamide

Purity: ≥98%

Formula Markup: C25H39NO2

Formula Weight: 385,6

Shelf life (days): 365

Notes: N-Acyl ethanolamines (NAEs) have diverse biological actions that are strongly affected by the associated acyl group. Docosahexaenoyl ethanolamide (DHEA) has potential signaling roles in cancer, inflammation, and neurological development and functioning.{21496,19917,19740,13859} At least some of DHEA’s effects are mediated through cannabinoid (CB) receptors, while some NAEs also act as vanilloid receptor agonists and voltage-gated K+ channel blockers.{21496,13859,19780} (R)-(−)-Docosahexaenyl-2’-hydroxy-1’-propylamide is a homolog of DHEA, characterized by the addition of an (R)-β-methyl group at the terminal ethanolamine carbon. A similar modification of arachidonoyl ethanolamide (Item No. 90050) to produce R-2 methanandamide (Item No. 90074) imparts diminished affinity for the CB receptor as well as reduced metabolic stability.{1092} The physiological actions of this compound have not been evaluated.
Mehr Informationen
Artikelnummer CAY9001230-5
Hersteller Cayman Chemical
Hersteller Artikelnummer 9001230-5
Green Labware Nein
Verpackungseinheit 5 mg
Mengeneinheit STK
Produktinformation (PDF) Download
MSDS (PDF) Download